The FDA has granted Breakthrough Device Designations to two 15-minute rapid tests for detecting Candida auris and carbapenem-resistant Acinetobacter baumannii, both identified by WHO as critical priority pathogens.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
The Elecsys pTau-181 test helps primary care clinicians rule out Alzheimer's disease in symptomatic patients aged 55 and older.
Cenevo has launched two AI agents for lab workflow automation, aiming to cut manual work and implementation costs by up to 50%, according to the company. The agents support protocol digitization and no-code workflow generation.
The 3-test panel detects antibodies for parasitic infections that affect up to 45 million people globally and are linked to bile duct cancer.
